Prospective observational cohorts at the Baylor college of medicine children’s foundation – Uganda COE
A cross sectional study of children and adolescent aged 6-19 years living with HIV and receiving ART to determine the …
Baylor-Uganda is part of this ongoing multi-centre parallel, observational cohort study among HIV-uninfected pregnant adolescents and young women (aged 16-24) since March 2019.
This is a phase III randomised open-label clinical trial assessing virologic efficacy and safety of Dolutegravir-containing versus Efavirenz-containing ART regimens in HIV-1 infected pregnant women and their infants.
Compares safety and antiretroviral effect of current standard ART to once daily intergrase inhibitor (INSTI) administered with darunavir/ritonavir (DRV/r) in …